< Back to situations

[PERSON]

Chloe Bloom

Featured in 4 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

245 clusters · 889 sources · last updated

Latest: Medical experts propose management system for GLP-1 obesity drugs

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. While research suggests secondary benefits—including a 21% lower risk of fragili

[ACTIVE] [HEALTH] [US] [GB] [DE]

Expanded therapeutic research on metformin and semaglutide

11 clusters · 92 sources · last updated

Latest: Semaglutide linked to significant reduction in asthma and COPD attacks

Recent medical research has identified expanded therapeutic potential for diabetes and obesity medications, specifically metformin and semaglutide, regarding brain health, organ function, and aging. Studies from Baylor C